News

The objective of the multinational study was to evaluate the long-term safety and effectiveness of Elidel (pimecrolimus) in pediatric and adult patients with eczema of any severity, who

The in vivo study will use a recognized animal model of chronic inflammatory diseases, the HLA-B27T transgenic rat model. The study should be completed by the end of

The regulator has stated that the medications should no longer be used by patients who have suffered or are at high risk of having a heart attack, stroke

“We are actively expanding our international marketing function and intend to invest in a vaccine filling line to ensure security of supply for these customers,” commented Peter Wulff,

A month’s supply of Combivir (a combination of Epivir and Retrovir) costs GBP319 ($605) in the UK but sells for just GBP10 in Africa. The huge margin for

Novartis has signed definitive agreements to acquire 100% of Hexal, Germany’s number two generics company, and a 67.7% stake in Eon Labs, a growing US generics company that

After three days of hearings, an FDA advisory panel reportedly voted 17-15 to return Vioxx to the market, a closer vote than those for Celebrex and Bextra, which

Data from the questionnaire showed that, at three months, nearly 30% of psoriasis patients who were taking Enbrel (etanercept) reported that they were ‘not at all’ bothered by

The findings from the MLN2704 single ascending dose trial indicated that the novel antibody-chemotherapeutic was well tolerated and produced sustained anti-tumor activity, including one patient who achieved a